Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEDROXYPROGESTERONE Cause Neoplasm progression? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Neoplasm progression have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 0.1% of all adverse event reports for MEDROXYPROGESTERONE.

6
Reports of Neoplasm progression with MEDROXYPROGESTERONE
0.1%
of all MEDROXYPROGESTERONE reports
3
Deaths
0
Hospitalizations

How Dangerous Is Neoplasm progression From MEDROXYPROGESTERONE?

Of the 6 reports, 3 (50.0%) resulted in death.

Is Neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEDROXYPROGESTERONE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does MEDROXYPROGESTERONE Cause?

Meningioma (1,364) Drug dose omission by device (510) Device leakage (500) Incorrect dose administered by device (410) Drug ineffective (403) Off label use (390) Syringe issue (354) Needle issue (346) Headache (288) Device occlusion (284)

What Other Drugs Cause Neoplasm progression?

PALBOCICLIB (10,885) SUNITINIB MALATE (1,920) CYCLOPHOSPHAMIDE (1,588) CARBOPLATIN (1,370) AXITINIB (1,315) DOXORUBICIN (1,276) LETROZOLE (1,225) PACLITAXEL (1,180) CRIZOTINIB (1,161) VINCRISTINE (1,106)

Which MEDROXYPROGESTERONE Alternatives Have Lower Neoplasm progression Risk?

MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE MEDROXYPROGESTERONE vs MEFENAMIC ACID MEDROXYPROGESTERONE vs MEFLOQUINE MEDROXYPROGESTERONE vs MEGESTROL MEDROXYPROGESTERONE vs MEGLUMINE

Related Pages

MEDROXYPROGESTERONE Full Profile All Neoplasm progression Reports All Drugs Causing Neoplasm progression MEDROXYPROGESTERONE Demographics